People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

If you have a cough and are putting it down to 'just you' or 'that illness' you've had for weeks, you should see a GP, a ...

The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Healthy Georgia report from the Augusta University School of Public Health came out and shows how Georgia residents are doing ...

Everyone loves a breath of fresh air. Unfortunately, too often our air is anything but fresh. While air quality varies ...

2021年3月，青岛市市立医院联合新墨西哥大学在International Journal of Chronic Obstructive Pulmonary Disease（IF2.7001/3区）上在线发表了一篇论文。在发表4年后，因图片组内重复在pubpeer上被读者质疑。 论文题为“Quantitative CT Analysis of Small Airway Remodeling in ...

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...